Detects lincomycin in milk using a novel signal generation method, highlighting its potential for point-of-care applications.
> 0.99). The constructed stable signal-output, long-lived CL signaling platform lays a solid theoretical and technical foundation for the development of next-generation highly sensitive and robust immunoassays suitable for point-of-care testing and resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: